Approvals/TGA/RILAST TURBUHALER budesonide / formoterol (eformoterol) fumarate dihydrate 200 micrograms/6 micrograms powder for inhalation dry powder inhaler

Approved

STANDARD

RILAST TURBUHALER budesonide / formoterol (eformoterol) fumarate dihydrate 200 micrograms/6 micrograms powder for inhalation dry powder inhaler

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 29, 2025
Approval ID: d969f506bc4660fd
Company: AstraZeneca Pty Ltd
Type: Standard

Approval Details

Approval Id: d969f506bc4660fd
Product Name: RILAST TURBUHALER budesonide / formoterol (eformoterol) fumarate dihydrate 200 micrograms/6 micrograms powder for inhalation dry powder inhaler
Artg Id: 295674
Artg Name: RILAST TURBUHALER 200/6 powder for inhalation dry powder inhaler
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2017-12-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/5238db48616dd11273174855f183c8d7.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d3f36840f0834902f0109c7a47f83dd0.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

d969f506bc4660fd

Type

Standard

Back to TGA Approvals